kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Multiple Strategies to Develop Small
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Mutant KRas Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions ScienceDirect
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



